Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N-[2-(o-chlorophenoxy)-ethyl]-cyclopropylamine.
D000818:Animals; D001921:Brain / Q000201:enzymology* / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D003521:Cyclopropanes / Q000494:pharmacology*; D003864:Depression, Chemical; D004285:Dogs; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D007737:Kynurenine; D008928:Mitochondria / Q000201:enzymology*; D008930:Mitochondria, Liver / Q000201:enzymology*; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010627:Phenethylamines; D011437:Propylamines / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000378:metabolism*; D013268:Stimulation, Chemical; D014363:Tryptamines / Q000652:urine*; D014439:Tyramine
D003521:Cyclopropanes; D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D011437:Propylamines; D014363:Tryptamines; D012701:Serotonin; D007737:Kynurenine; D008995:Monoamine Oxidase; D014439:Tyramine